Janssen-Cilag International NV
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- PARIET gastro-resistant tablet 10 mg
- PARIET gastro-resistant tablet 20 mg
- B03 - Preparados antianémicos
- EPREX PREFILLED SYRINGE solution for injection 10 000 IU/1 ml
- EPREX PREFILLED SYRINGE solution for injection 2 000 IU/1 ml
- EPREX PREFILLED SYRINGE solution for injection 4 000 IU/1 ml
- D01 - Antifúngicos para uso dermatológico
- DAKTARIN cutaneous powder 2%
- G01 - Antiinfecciosos y antisépticos ginecológicos
- GYNO-DAKTARIN vaginal capsule, hard 400 mg
- GYNO-DAKTARIN vaginal cream 2%
- N02 - Analgésicos
- DUROGESIC D TRANS transdermal patch 100 µg/h
- DUROGESIC D TRANS transdermal patch 12 µg/h
- DUROGESIC D TRANS transdermal patch 25 µg/h
- DUROGESIC D TRANS transdermal patch 50 µg/h
- DUROGESIC D TRANS transdermal patch 75 µg/h
- N03 - Antiepilépticos
- TOPAMAX capsule, hard 15 mg
- TOPAMAX capsule, hard 25 mg
- TOPAMAX capsule, hard 50 mg
- TOPAMAX film-coated tablet 100 mg
- TOPAMAX film-coated tablet 200 mg
- TOPAMAX film-coated tablet 25 mg
- TOPAMAX film-coated tablet 50 mg
- N05 - Psicolépticos
- HALDOL DECANOATE solution for injection 100 mg/1 ml
- HALDOL DECANOATE solution for injection 50 mg/1 ml
- HALDOL tablet 5 mg
- RISPERDAL CONSTA powder and solvent for suspension for injection 25 mg
- RISPERDAL CONSTA powder and solvent for suspension for injection 37.5 mg
- RISPERDAL CONSTA powder and solvent for suspension for injection 50 mg
- RISPERDAL film-coated tablet 1 mg
- RISPERDAL film-coated tablet 2 mg
- RISPERDAL film-coated tablet 3 mg
- RISPERDAL oral solution 1 mg/ ml
- N06 - Psicoanalépticos
- CONCERTA prolonged-release tablet 18 mg
- CONCERTA prolonged-release tablet 36 mg
- CONCERTA prolonged-release tablet 54 mg
- CONCERTA XL prolonged-release tablet 27 mg
- REMINYL oral solution 4 mg/ml
- N07 - Otros fármacos activos sobre el sistema nervioso
- STUGERON tablet 25 mg
- P02 - Antihelmínticos
- VERMOX oral suspension 100 mg/5 ml
- VERMOX tablet 100 mg